A large clinical trial testing a once-daily inhaled treatment for PAH is now recruiting, after data showed long-term benefits ...

High concentrations of a heart-related protein in pregnant women with PAH show those at a high risk of complications after ...

Respiratory rehabilitation is safe and can help improve exercise capacity in people with chronic obstructive pulmonary disease (COPD) with or without pulmonary hypertension (PH), a study reported. A ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Pulmonary hypertension (PH) is a rare but severe condition characterized by high blood pressure that affects pulmonary arteries – the vessels responsible for transporting blood from the heart to the ...

[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a rare but severe disease characterized by high blood pressure in the lungs. The disease affects the pulmonary arteries, which are ...

Pulmonary hypertension (PH) is characterized by high blood pressure, which affects the pulmonary arteries, the vessels that transport blood from the heart to the lungs. Due to the thickened and ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

At the Pulmonary Hypertension Association’s (PHA) biannual conference, it is easy to feel like you should be able to do more. There are sessions to attend, people to meet, dinners to join, and ...

Third Pole Therapeutics said it has successfully completed an early feasibility study of its portable inhaled nitric oxide (iNO) delivery device, eNOfit, allowing the company to move to larger trials ...

Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears to be working as intended, according to newly ...

Researchers identified two genes — PRDX1 and TNFAIP3 — whose activity levels could serve as diagnostic biomarkers for idiopathic pulmonary arterial hypertension (PAH). The genes are related to ...